clarithromycin has been researched along with Phlegmon in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Arellano-Mendoza, I; Lopez-Cordero, S; Mercadillo-Perez, P; Peniche-Castellanos, A; Valle-Espinosa, ED | 1 |
Kim, HY; Kim, SH; Kim, YM; Yoo, HW | 1 |
Baluch, A; Pasikhova, Y; Snyder, M | 1 |
Hsieh, CJ; Hsueh, PR; Hwang, KP; Kuo, KC | 1 |
Armstrong, WS; Eaton, ME; Kelley, CF | 1 |
Dudler, J; Gerster, JC | 1 |
Cone, LA; Dietrich, EJ; Nazemi, R; Sneider, RA | 1 |
Brown, BA; Onyi, GO; Wallace, RJ | 1 |
8 other study(ies) available for clarithromycin and Phlegmon
Article | Year |
---|---|
Topics: Adult; Cellulitis; Clarithromycin; Diagnosis, Differential; Female; Humans; Mycobacterium chelonae; Skin Diseases; Skin Diseases, Infectious; Ulcer | 2023 |
Wells' syndrome related to Mycoplasma pneumoniae in a 5-year-old boy.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Biopsy; Cellulitis; Child, Preschool; Clarithromycin; Eosinophilia; Humans; Male; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Prednisolone; Radiography; Treatment Outcome | 2020 |
Successful management of Mycobacterium haemophilum lower extremity cutaneous infection in a matched-unrelated donor stem cell transplant recipient.
Topics: Anti-Bacterial Agents; Biopsy; Cellulitis; Ciprofloxacin; Clarithromycin; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lower Extremity; Middle Aged; Mycobacterium haemophilum; Mycobacterium Infections, Nontuberculous; Opportunistic Infections; Rifabutin; Tacrolimus; Unrelated Donors | 2017 |
Facial cellulitis because of Aggregatibacter (Actinobacillus) actinomycetemcomitans and Capnocytophaga species in an immunocompetent patient.
Topics: Actinobacillus Infections; Administration, Oral; Adolescent; Aggregatibacter actinomycetemcomitans; Amikacin; Capnocytophaga; Cellulitis; Clarithromycin; Face; Female; Gram-Negative Bacterial Infections; Humans | 2011 |
Disseminated Mycobacterium haemophilum infection.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Anti-HIV Agents; Cellulitis; Clarithromycin; HIV; Humans; Immunocompromised Host; Male; Middle Aged; Mycobacterium haemophilum; Mycobacterium Infections; Ofloxacin; Rifabutin | 2011 |
Cellulitis caused by Capnocytophaga cynodegmi associated with etanercept treatment in a patient with rheumatoid arthritis.
Topics: Animals; Anti-Bacterial Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Bites and Stings; Capnocytophaga; Cats; Cellulitis; Clarithromycin; Etanercept; Female; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunoglobulin G; Middle Aged; Receptors, Tumor Necrosis Factor; Treatment Outcome | 2004 |
Mania due to clarithromycin therapy in a patient who was not infected with human immunodeficiency virus.
Topics: Aged; Animals; Arm Injuries; Bipolar Disorder; Cellulitis; Clarithromycin; Dogs; Fever; Humans; Male | 1996 |
Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin.
Topics: Abscess; Administration, Oral; Adrenal Cortex Hormones; Anti-Bacterial Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Catheters, Indwelling; Cellulitis; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Organ Transplantation; Osteomyelitis; Risk Factors; Skin Diseases, Infectious; United States | 1992 |